Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Spotlight

Articles of Significant Interest Selected from This Issue by the Editors

DOI: 10.1128/JVI.01105-17
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

A Highly Divergent Coronavirus from the Asian House Shrew

Although shrews comprise one of the largest groups of mammals, little is known about their role in the evolution and transmission of coronaviruses (CoVs). Wang et al. (e00764-17) discovered a CoV, Wénchéng shrew virus (WESV), in Asian house shrews from China. WESV is most closely related to alphacoronaviruses but sufficiently divergent to be considered a new member of the genus Alphacorionavirus. The WESV genome contains a distinct S gene and a unique NS7 gene. These data suggest that shrews are natural reservoirs for CoV and have influenced CoV evolution.

Figure1
  • Open in new tab
  • Download powerpoint

Phylogenetic relationship between Wénchéng shrew virus and known CoVs.

Identification and Quantification of Hepatitis B Virus DNA Intermediate

Hepatitis B virus (HBV) persistence is maintained by its nuclear episome, a covalently closed circular (CCC) DNA, which is formed from a relaxed circular (RC) DNA. Luo et al. (e00539-17) identify an intermediate in RC to CCC DNA conversion, the closed minus-strand RC (cM-RC) DNA. Exonucleases that selectively degrade RC but not CCC DNA allowed identification of this intermediate and precise quantification of CCC DNA. Identifying cM-RC DNA as an intermediate elucidates CCC DNA formation pathways and mechanisms of HBV persistence.

Figure2
  • Open in new tab
  • Download powerpoint

Closed minus-strand intermediate in HBV RC to CCC DNA conversion.

Insights into Recognition of HIV Peptides by δ/αβ T Cell Receptors

The central interaction in T cell-mediated adaptive immunity is between the T cell receptor (TCR) and the antigen-presenting molecule loaded with a given antigen. Shi et al. (e00725-17) resolved the complex structures of two high-affinity δ/αβTCRs containing the same Vδ1 region bound to different locus-disparate class I major histocompatibility complex molecules loaded with HIV peptides. The δ/αβTCRs used a conserved CDR1δ loop to contact the ligands. The crystal structures and binding analyses illuminate TCR recognition and suggest ways to shape the δ/αβTCR repertoire to inhibit infection.

Figure3
  • Open in new tab
  • Download powerpoint

Conserved Vδ1 loop signature revealed by the top view of CDR loop footprints of the two δ/αβTCRs.

Dissecting Immune Response with an Anti-idiotypic Antibody

Anti-idiotypic antibodies can be employed as precise tools for analyzing immune responses and improving vaccines. Wong et al. (e00406-17) define the structural footprint of an anti-idiotype antibody, E1, which is specific for the HM14c10 antibody. E1 is a potent, fully human dengue virus serotype 1 (DENV1) envelope protein-specific antibody that can serve as a useful marker to follow anti-DENV1 immune responses and can be further engineered as an immunogen to elicit an anti-DENV immune response.

Figure4
  • Open in new tab
  • Download powerpoint

Structural mimicry of the flavivirus envelope E protein by the E1 anti-idiotypic antibody.

Vesicular Stomatitis Virus Pseudovirion Vaccine Protects against Ebola Virus

A recombinant, infectious vesicular stomatitis virus (VSV) encoding the Ebola virus glycoprotein effectively prevents Ebola virus-associated disease. A vaccine composed of VSV pseudovirions bearing Ebola virus glycoprotein may prove efficacious and have a better safety profile. Lennemann et al. (e00479-17) tested the efficacy of VSV pseudovirions containing Ebola virus glycoprotein and lacking the native G glycoprotein as a vaccine platform. The Ebola virus glycoprotein vaccine in the absence of an adjuvant provides robust protection of Ebola virus-challenged mice. Furthermore, removal of the N-linked glycans surrounding conserved regions of the glycoprotein does not alter vaccine efficacy.

Figure5
  • Open in new tab
  • Download powerpoint

VSV-based Ebola vaccine protects mice from mouse-adapted Ebola virus challenge.

  • Copyright © 2017 American Society for Microbiology.

All Rights Reserved .

PreviousNext
Back to top
Download PDF
Citation Tools
Articles of Significant Interest Selected from This Issue by the Editors
Journal of Virology Aug 2017, 91 (17) e01105-17; DOI: 10.1128/JVI.01105-17

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Articles of Significant Interest Selected from This Issue by the Editors
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Articles of Significant Interest Selected from This Issue by the Editors
Journal of Virology Aug 2017, 91 (17) e01105-17; DOI: 10.1128/JVI.01105-17
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • A Highly Divergent Coronavirus from the Asian House Shrew
    • Identification and Quantification of Hepatitis B Virus DNA Intermediate
    • Insights into Recognition of HIV Peptides by δ/αβ T Cell Receptors
    • Dissecting Immune Response with an Anti-idiotypic Antibody
    • Vesicular Stomatitis Virus Pseudovirion Vaccine Protects against Ebola Virus
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514